iifl-logo

Venus Remedies Ltd AGM

453.1
(-0.63%)
Sep 1, 2025|01:24:43 PM

Venus Remedies CORPORATE ACTIONS

01/09/2024calendar-icon
01/09/2025calendar-icon
PurposeAGM DateAnnouncement Date
AGM22 Aug 20258 Jul 2025
approved as below: 1. The date of 36th Annual General Meeting fixed as 22nd August 2025 at 11:30 a.m. (1ST) through Video Conferencing (VC) I Other Audio-Visual Means (OAVM). 2. The book closure (Register of Members and Share Transfer Books) for the purpose of 36th Annual General Meeting will commence from 16th August 2025 to 22nd August 2025 (both days inclusive). 3. The cut-off date for determining eligible shareholders for remote e-voting/ e- voting will be on 15th August 2025. Any person, who is a member of the company as on 15th August 2025, shall be entitled to vote through remote e-voting/ e- voting. The remote e-voting peri-od commences on 19th August 2025 (9:00 a.m.) and ends on 21st August 2025 (5 :00 p.m.). AGM date prior notice in Newspaper. (As Per BSE Announcement Dated on: 11.07.2025) Proceedings of 36th Annual General Meeting (As per BSE Announcement Dated on 22/08/2025)
AGM23 Sep 202421 Aug 2024
Details of 35th Annual general Meeting as per the Copy of notice enclosed herewith. Proceedings of 35th Annual General Meeting. (As Per BSE Announcement dated on 23.09.2024) Voting Results of 35th AGM. (As per BSE Announcement Dated on 24/09/2024)

Venus Remedies: Related News

Venus Remedies Secures Ukrainian GMP Certification for Baddi Facility
22 May 2025|12:41 PM

The Unit-II Baddi plant, which got the renewed certification, has state-of-art infrastructure and state-of-the-art manufacturing technology to cater to complex therapeutic segments in an efficient manner. 

Read More
Venus Remedies Secures Key Approvals, Strengthens Global Market Reach
31 Dec 2024|09:16 PM

The company is now set to further expand into Eastern Europe as this recognition ensures patients and healthcare providers have access to reliable and effective antibiotics.

Read More
Venus Remedies gets approval for pre-filled syringe facility
6 Nov 2024|10:36 AM

Furthermore, the NPRA's recognition will enable Venus Remedies to capitalise on the expanding global demand for enoxaparin.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.